Adicet Bio, Inc. (ACET)
NASDAQ: ACET · IEX Real-Time Price · USD
1.100
-0.050 (-4.35%)
At close: Jul 2, 2024, 4:00 PM
1.090
-0.010 (-0.91%)
After-hours: Jul 2, 2024, 7:36 PM EDT
Adicet Bio Stock Forecast
ACET's stock price has decreased by -59.71% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Adicet Bio stock have an average target of 15.17, with a low estimate of 5.00 and a high estimate of 27. The average target predicts an increase of 1,279.09% from the current stock price of 1.10.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Adicet Bio stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 3 | 3 | 3 | 3 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 8 | 8 | 8 | 8 | 7 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +809.09% | Jun 24, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +809.09% | Jun 5, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +809.09% | May 15, 2024 |
Wedbush | Wedbush | Buy Reiterates $5 | Buy | Reiterates | $5 | +354.55% | Apr 23, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +809.09% | Apr 2, 2024 |
Financial Forecast
Revenue This Year
1.70M
Revenue Next Year
3.19M
from 1.70M
Increased by 87.53%
EPS This Year
-1.48
from -3.31
EPS Next Year
-1.61
from -1.48
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 15.8M | 26.3M | 222.5M | 475.3M | 134.0M |
Avg | 1.7M | 3.2M | 34.5M | 116.1M | 71.7M |
Low | n/a | n/a | n/a | n/a | 10.7M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | 1,444.1% | 6,878.7% | 1,276.9% | 15.4% |
Avg | - | 87.5% | 982.7% | 236.5% | -38.3% |
Low | - | - | - | - | -90.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.28 | -0.93 | 0.56 | 2.73 | -1.04 |
Avg | -1.48 | -1.61 | -1.33 | 0.77 | -1.01 |
Low | -1.59 | -3.26 | -3.71 | -1.07 | -0.97 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.